Bayer AG
BAYRY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $47 | $48 | $51 | $44 |
| % Growth | -2.2% | -6.1% | 15.1% | – |
| Cost of Goods Sold | $21 | $20 | $20 | $17 |
| Gross Profit | $25 | $28 | $31 | $27 |
| % Margin | 54.4% | 58.5% | 60.8% | 61.9% |
| R&D Expenses | $6 | $5 | $7 | $5 |
| G&A Expenses | $3 | $2 | $3 | $3 |
| SG&A Expenses | $16 | $15 | $17 | $15 |
| Sales & Mktg Exp. | $13 | $12 | $14 | $12 |
| Other Operating Expenses | -$0 | $8 | $0 | -$0 |
| Operating Expenses | $22 | $28 | $24 | $20 |
| Operating Income | $3 | -$0 | $6 | $7 |
| % Margin | 7.1% | -0.3% | 12.3% | 15.8% |
| Other Income/Exp. Net | -$6 | -$1 | -$4 | $2 |
| Pre-Tax Income | -$2 | -$2 | $5 | $2 |
| Tax Expense | $0 | $1 | $1 | $1 |
| Net Income | -$3 | -$3 | $4 | $1 |
| % Margin | -5.5% | -6.2% | 8.2% | 2.3% |
| EPS | -0.65 | -0.75 | 1.06 | 0.26 |
| % Growth | 13.3% | -170.8% | 307.7% | – |
| EPS Diluted | -0.65 | -0.75 | 1.06 | 0.26 |
| Weighted Avg Shares Out | 4 | 4 | 4 | 4 |
| Weighted Avg Shares Out Dil | 4 | 4 | 4 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $1 |
| Depreciation & Amortization | $9 | $10 | $4 | $4 |
| EBITDA | $9 | $4 | $10 | $7 |
| % Margin | 18.9% | 8.8% | 20.6% | 15.8% |